These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21454696)

  • 1. Functional activation of Src family kinase yes protein is essential for the enhanced malignant properties of human melanoma cells expressing ganglioside GD3.
    Hamamura K; Tsuji M; Hotta H; Ohkawa Y; Takahashi M; Shibuya H; Nakashima H; Yamauchi Y; Hashimoto N; Hattori H; Ueda M; Furukawa K; Furukawa K
    J Biol Chem; 2011 May; 286(21):18526-37. PubMed ID: 21454696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ganglioside GD3 enhances adhesion signals and augments malignant properties of melanoma cells by recruiting integrins to glycolipid-enriched microdomains.
    Ohkawa Y; Miyazaki S; Hamamura K; Kambe M; Miyata M; Tajima O; Ohmi Y; Yamauchi Y; Furukawa K; Furukawa K
    J Biol Chem; 2010 Aug; 285(35):27213-27223. PubMed ID: 20581115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of malignant properties of human osteosarcoma cells with disialyl gangliosides GD2/GD3.
    Shibuya H; Hamamura K; Hotta H; Matsumoto Y; Nishida Y; Hattori H; Furukawa K; Ueda M; Furukawa K
    Cancer Sci; 2012 Sep; 103(9):1656-64. PubMed ID: 22632091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focal adhesion kinase as well as p130Cas and paxillin is crucially involved in the enhanced malignant properties under expression of ganglioside GD3 in melanoma cells.
    Hamamura K; Tsuji M; Ohkawa Y; Nakashima H; Miyazaki S; Urano T; Yamamoto N; Ueda M; Furukawa K; Furukawa K
    Biochim Biophys Acta; 2008 Mar; 1780(3):513-9. PubMed ID: 18078823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ganglioside GD3 Enhances Invasiveness of Gliomas by Forming a Complex with Platelet-derived Growth Factor Receptor α and Yes Kinase.
    Ohkawa Y; Momota H; Kato A; Hashimoto N; Tsuda Y; Kotani N; Honke K; Suzumura A; Furukawa K; Ohmi Y; Natsume A; Wakabayashi T; Furukawa K
    J Biol Chem; 2015 Jun; 290(26):16043-58. PubMed ID: 25940087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of caveolin-1 in a human melanoma cell line results in dispersion of ganglioside GD3 from lipid rafts and alteration of leading edges, leading to attenuation of malignant properties.
    Nakashima H; Hamamura K; Houjou T; Taguchi R; Yamamoto N; Mitsudo K; Tohnai I; Ueda M; Urano T; Furukawa K; Furukawa K
    Cancer Sci; 2007 Apr; 98(4):512-20. PubMed ID: 17284246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GM1 / GD1b / GA1 synthase expression results in the reduced cancer phenotypes with modulation of composition and raft-localization of gangliosides in a melanoma cell line.
    Dong Y; Ikeda K; Hamamura K; Zhang Q; Kondo Y; Matsumoto Y; Ohmi Y; Yamauchi Y; Furukawa K; Taguchi R; Furukawa K
    Cancer Sci; 2010 Sep; 101(9):2039-47. PubMed ID: 20594196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A therapeutic trial of human melanomas with combined small interfering RNAs targeting adaptor molecules p130Cas and paxillin activated under expression of ganglioside GD3.
    Makino Y; Hamamura K; Takei Y; Bhuiyan RH; Ohkawa Y; Ohmi Y; Nakashima H; Furukawa K; Furukawa K
    Biochim Biophys Acta; 2016 Aug; 1860(8):1753-63. PubMed ID: 27068854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ganglioside GD3 promotes cell growth and invasion through p130Cas and paxillin in malignant melanoma cells.
    Hamamura K; Furukawa K; Hayashi T; Hattori T; Nakano J; Nakashima H; Okuda T; Mizutani H; Hattori H; Ueda M; Urano T; Lloyd KO; Furukawa K
    Proc Natl Acad Sci U S A; 2005 Aug; 102(31):11041-6. PubMed ID: 16040804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential roles of integrin-mediated signaling for the enhancement of malignant properties of melanomas based on the expression of GD3.
    Ohkawa Y; Miyazaki S; Miyata M; Hamamura K; Furukawa K; Furukawa K
    Biochem Biophys Res Commun; 2008 Aug; 373(1):14-9. PubMed ID: 18538130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neogenin, Defined as a GD3-associated Molecule by Enzyme-mediated Activation of Radical Sources, Confers Malignant Properties via Intracytoplasmic Domain in Melanoma Cells.
    Kaneko K; Ohkawa Y; Hashimoto N; Ohmi Y; Kotani N; Honke K; Ogawa M; Okajima T; Furukawa K; Furukawa K
    J Biol Chem; 2016 Aug; 291(32):16630-43. PubMed ID: 27288875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ganglioside GD3 induces convergence and synergism of adhesion and hepatocyte growth factor/Met signals in melanomas.
    Furukawa K; Kambe M; Miyata M; Ohkawa Y; Tajima O; Furukawa K
    Cancer Sci; 2014 Jan; 105(1):52-63. PubMed ID: 24372645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ganglioside GD2 Enhances the Malignant Phenotypes of Melanoma Cells by Cooperating with Integrins.
    Yesmin F; Bhuiyan RH; Ohmi Y; Yamamoto S; Kaneko K; Ohkawa Y; Zhang P; Hamamura K; Cheung NV; Kotani N; Honke K; Okajima T; Kambe M; Tajima O; Furukawa K; Furukawa K
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrin alpha4beta1 promotes focal adhesion kinase-independent cell motility via alpha4 cytoplasmic domain-specific activation of c-Src.
    Hsia DA; Lim ST; Bernard-Trifilo JA; Mitra SK; Tanaka S; den Hertog J; Streblow DN; Ilic D; Ginsberg MH; Schlaepfer DD
    Mol Cell Biol; 2005 Nov; 25(21):9700-12. PubMed ID: 16227616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biosignals modulated by tumor-associated carbohydrate antigens: novel targets for cancer therapy.
    Furukawa K; Hamamura K; Aixinjueluo W; Furukawa K
    Ann N Y Acad Sci; 2006 Nov; 1086():185-98. PubMed ID: 17185516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic stretch induces reorientation of cells in a Src family kinase- and p130Cas-dependent manner.
    Niediek V; Born S; Hampe N; Kirchgessner N; Merkel R; Hoffmann B
    Eur J Cell Biol; 2012 Feb; 91(2):118-28. PubMed ID: 22178114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disialyl gangliosides enhance tumor phenotypes with differential modalities.
    Furukawa K; Hamamura K; Ohkawa Y; Ohmi Y; Furukawa K
    Glycoconj J; 2012 Dec; 29(8-9):579-84. PubMed ID: 22763744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic analysis of ganglioside-associated membrane molecules: substantial basis for molecular clustering.
    Hashimoto N; Hamamura K; Kotani N; Furukawa K; Kaneko K; Honke K; Furukawa K
    Proteomics; 2012 Nov; 12(21):3154-63. PubMed ID: 22936677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of GD3 ganglioside and its O-acetylated derivative by stable transfection with antisense vector against GD3-synthase gene expression in hamster melanoma cells: effects on cellular growth, melanogenesis, and dendricity.
    Birklé S; Gao L; Zeng G; Yu RK
    J Neurochem; 2000 Feb; 74(2):547-54. PubMed ID: 10646505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deacetylated GM3 promotes uPAR-associated membrane molecular complex to activate p38 MAPK in metastatic melanoma.
    Yan Q; Bach DQ; Gatla N; Sun P; Liu JW; Lu JY; Paller AS; Wang XQ
    Mol Cancer Res; 2013 Jun; 11(6):665-75. PubMed ID: 23525268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.